Takeaway: For HFpEF patients with obesity + T2D, GLP-1s and dual agonists are emerging not only as metabolic therapies but as cardiovascular disease-modifying agents
A dedicated sub study in patients with type 2 diabetes, published in The Lancet Diabetes & Endocrinology , confirmed this picture: gastrointestinal side effects were the most common adverse events, but no deaths were reported during the trial period
Common Neurobion Forte Injection side effects are: Injection site pain Redness or swelling Nausea Headache Dizziness Stomach discomfort Skin rash or itching These effects are usually temporary and do not require medical attention
According to the medicine's information leaflet, patients might experience headaches, dizziness, nausea, or a general feeling of being unwell
However, when accounting for weight, no significant BMC shift was observed